FDA puts on hold Keytruda studies

6th July 2017 Uncategorised 0

US regulators have placed on clinical hold three studies testing the immunotherapy Keytruda in combination with other therapies for multiple myeloma because of patient deaths.

More: FDA puts on hold Keytruda studies
Source: News